Levin named director of DTC at AbelsonTaylor

Share this article:
AbelsonTaylor named David Levin director of DTC. Levin, who was previously VP account director at Draft, reports to SVP and director of client services Jay Carter. He replaces Richard Blocki, who left to found his own company. Levin's past work includes the launch of Novartis' Zelnorm and campaigns for Pfizer's Zoloft and Zyrtec.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.